Avg closing price
Price range

13 Jim Simons Theravance Biopharma Trades

The first Theravance Biopharma trade was made in Q4 2014. Since then Jim Simons bought shares six more times and sold shares on six occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Theravance Biopharma anymore.

Avg closing price
Price range
Sold -176 Thousand shares Q1 2023
Avg closing price $10.57
Price range $9.87 - $11.44
Increased shares by 15.9% (+24.2 Thousand shares) Q4 2022
Avg closing price $10.51
Price range $9.65 - $11.34
New holding (+152 Thousand shares) Q3 2022
Avg closing price $9.37
Price range $8.39 - $10.22
Sold -17 Thousand shares Q1 2020
Avg closing price $25.03
Price range $17.84 - $31.21
New holding (+17 Thousand shares) Q4 2019
Avg closing price $19.43
Price range $16.12 - $25.89
Sold -40.3 Thousand shares Q2 2018
Avg closing price $23.74
Price range $22.06 - $25.52
New holding (+40.3 Thousand shares) Q1 2018
Avg closing price $27.46
Price range $23.37 - $29.71
Sold -10.9 Thousand shares Q1 2016
Avg closing price $16.36
Price range $13.35 - $18.80
New holding (+10.9 Thousand shares) Q4 2015
Avg closing price $15.87
Price range $11.13 - $19.51
Sold -264 Thousand shares Q3 2015
Avg closing price $12.73
Price range $10.88 - $14.80
New holding (+264 Thousand shares) Q2 2015
Avg closing price $15.51
Price range $12.57 - $18.63
Sold -14.1 Thousand shares Q1 2015
Avg closing price $18.33
Price range $14.70 - $21.73
New holding (+14.1 Thousand shares) Q4 2014
Avg closing price $17.41
Price range $13.33 - $23.19

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!